Whale Analyzer
SEC 13F · Available

Cevian Capital II GP 13F Holdings and Portfolio Changes

Cevian Capital II GP reported $3.70B in 13F securities for Q2 2026, with 3 positions. Values are as of the report date; option positions, when present, use underlying-security values. This is not complete fund assets or investment performance.

Open interactive portfolio
$3.70B13F reported value
3Holdings
2026-06-30Report date
2026-08-14Filing date

Latest 13F portfolio changes

New or increased positions are not listed in the available comparison data. Reduced or exited positions include CRH. These are comparisons between reported positions, not a record of execution dates, prices or cash traded.

Latest filing metadata: quarter Q2 2026; report date 2026-06-30; filing date 2026-08-14; disclosure source SEC 13F.

Reported holdings and concentration

Cevian Capital II GP's Q2 2026 13F report contains 3 positions valued at $3.70B. The largest reported holdings include UBS Group AG, AUTOLIV, and CRH.

The three largest positions in the holdings table account for approximately 100.0% of reported 13F value. The largest reported sector exposure is Financials at 64.5% of the disclosed portfolio.

The filing metadata lists report date 2026-06-30, filing date 2026-08-14, SEC accession 0000902664-26-003474. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.

Cevian Capital II GP portfolio analytics

the top five positions account for 100.0% of disclosed value; the largest sector exposure is Financials at 64.5%; latest prices differ from modeled cost estimates by an average 73.0% across 3 tracked positions (estimated costs, not reported purchase prices or actual investment returns).

Top reported holdings

HoldingReported valueWeightQuarter change
UBS whale holders
UBS Group AG
$2.38B64.5%Held
ALV whale holders
AUTOLIV INC
$731.7M19.8%Held
CRH whale holders
CRH PLC
$581.0M15.7%Reduced

New and increased positions

No reported items for this period.

Reduced and exited positions

Sorted by reported position value; exits use the prior report. These are not sale proceeds.

Allocation

  • Financials: 64.5%
  • Consumer Discretionary: 19.8%
  • Materials: 15.7%

Data notes

Report date: 2026-06-30

Disclosure source: SEC 13F

Read the original SEC filing (0000902664-26-003474)

SEC 13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.

This page is generated from public filings and public disclosures. It is for research and education only and is not investment advice.

Related investor portfolios

Learn more in Whale Analyzer Academy

Learn more in Whale Analyzer Academy:

Questions about this 13F filing

What does Cevian Capital II GP report for Q2 2026?

The filing reports 3 positions and $3.70B in 13F securities. The holdings table shows reported values and weights; option values follow the filing's reporting conventions.

What changed between filings?

New or increased positions are not listed in the available comparison data. Reduced or exited positions include CRH.

Do these amounts show how much was bought or sold?

No. The change lists are ranked by reported position value. Exited positions use their value in the prior report. These amounts are not execution prices, cash invested or sale proceeds.

Is this the current portfolio?

No. Form 13F is a quarter-end snapshot, generally filed within 45 days of quarter end. It excludes short positions and does not cover every asset. Compare the report date and filing date before using the data.

Read the 13F filing guide · Sources and methodology